This inventor holds 1 USPTO granted patent. Top assignee: Celtrix Pharmaceuticals, Inc.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Kimyen B Nguyen: Innovator in Recombinant Polypeptide Technology
Introduction
Kimyen B Nguyen is a notable inventor based in Union City, CA (US). He has made significant contributions to the field of biotechnology, particularly in the area of recombinant polypeptides. His innovative work has led to advancements that enhance the solubility and activity of these important biological molecules.
Latest Patents
Nguyen holds a patent for the invention titled "Expression of fusion polypeptides transported out of the cytoplasm." This invention focuses on the use of a fusion partner that lacks a leader sequence, which facilitates the expression of fusion proteins. These proteins are then effectively transported out of the cytoplasm, increasing their solubility and activity. The patent includes a nucleic acid encoding a fusion polypeptide that comprises a mature interleukin-1-like polypeptide or a leader-deleted-translocating polypeptide, along with a polypeptide of interest. Additionally, it encompasses host cells containing such nucleic acids and the methods for producing recombinant fusion polypeptides.
Career Highlights
Nguyen is currently associated with Celtrix Pharmaceuticals, Inc., where he continues to apply his expertise in biotechnology. His work at Celtrix has allowed him to collaborate with other talented professionals in the field, further enhancing the impact of his innovations.
Collaborations
Some of his notable coworkers include Desmond D Mascarenhas and Yang Zhang. Their collaborative efforts contribute to the advancement of research and development in the biotechnology sector.
Conclusion
Kimyen B Nguyen's contributions to the field of recombinant polypeptides exemplify the importance of innovation in biotechnology. His patent and ongoing work at Celtrix Pharmaceuticals, Inc. highlight his commitment to advancing scientific knowledge and improving therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile